Huiqun Wu

发表

Dihydrocelastrol inhibits multiple myeloma cell proliferation and promotes apoptosis through ERK1/2 and IL-6/STAT3 pathways in vitro and in vivo

Weiliang Zhu, Gege Chen, Gaomei Chang, 2017, Acta biochimica et biophysica Sinica.

A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma

Fengyuan Liu, Huiqun Wu, Wangrui Liu, 2022, Frontiers in Cellular and Infection Microbiology.

Single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation in multiple myeloma: a meta-analysis of randomized controlled trials.

F. Zhan, Jumei Shi, Guang Yang, 2015, International journal of clinical and experimental medicine.

PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1

Gaomei Chang, W. Xiao, Dandan Yu, 2018, Acta biochimica et biophysica Sinica.

Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression.

Dandan Yu, Huili Zhai, Liping Li, 2021, Acta biochimica et biophysica Sinica.

Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells.

Weiliang Zhu, Gege Chen, Zhijian Xu, 2020, Acta biochimica et biophysica Sinica.

Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2

Lu Gao, Jumei Shi, Guang Yang, 2015, BioMed research international.

Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.

Weiliang Zhu, Gege Chen, W. Xiao, 2019, Cancer letters.

The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.

Weiliang Zhu, Gege Chen, Gaomei Chang, 2017, Oncology reports.

Ferroportin downregulation promotes cell proliferation by modulating the Nrf2–miR-17-5p axis in multiple myeloma

F. Zhan, Gege Chen, Lu Gao, 2019, Cell Death & Disease.

DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K/AKT pathway in T-cell leukemia/lymphoma

Weiliang Zhu, Yunfei Zhou, W. Xiao, 2018, Acta biochimica et biophysica Sinica.

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I

F. Zhan, Hongwei Xu, Lu Gao, 2015, Oncotarget.

DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma.

Weiliang Zhu, Zhijian Xu, Lu Gao, 2019, Acta biochimica et biophysica Sinica.

Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo

Weiliang Zhu, Gege Chen, Gaomei Chang, 2016, International journal of molecular sciences.

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma

Weiliang Zhu, Yunfei Zhou, Gege Chen, 2017, Theranostics.

Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway.

Weiliang Zhu, Zhijian Xu, Yong Zhang, 2021, Acta biochimica et biophysica Sinica.

Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells.

F. Zhan, Hongwei Xu, Lu Gao, 2014, Acta biochimica et biophysica Sinica.